HIV/AIDS
New research from Spain, Brazil and the United States in the area of HIV/AIDS detailed
Published in AIDS Weekly, November 6th, 2006
Study 1: HIV/AIDS patients carrying the monocyte chemoattractant protein 1 mutated allele have a better response to protease inhibitor treatment.
"Antiretroviral drug efficacy has been widely studied in relation to viral factors. Mutations in the HIV coreceptors and their natural chemokines, however, may be critical in HIV infection and treatment response.
"We compared the efficacy of protease inhibitor (PI) treatment among PI-naive patients grouped according to whether they carried the chemokine CC motif receptor 2 (CCR-2) 64I and monocyte...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2006-11-06)
More Articles from AIDS Weekly
- HIV/AIDS & Cryptosporidiosis
Nitazoxanide safe and useful for treatment of AIDS-related cryptosporidiosis - HIV/AIDS & Oral Contraceptive
Progestin-based contraceptive suppresses cellular immunity in HIV infection - HIV/AIDS Drug Delivery
Lipid-associated indinavir delivery may improve HAART efficacy in HIV/AIDS - HIV/AIDS HAART
Nevirapine-containing HAART safe and effective long-term in drug-naive HIV/AIDS patients - HIV/AIDS Pathogenesis
HIV-1 Gag is highly mobile in living cells - Herpesvirus Immunology
Researchers at University of Washington, Department of Pathobiology publish new data on herpesvirus immunology - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
